Activity of coumermycin against clinical isolates of staphylococci.
Staphylococci, particularly methicillin-resistant strains of Staphylococcus aureus, are major nosocomial pathogens in large hospitals in eastern Australia. At present vancomycin is the drug of choice for the treatment of life-threatening methicillin-resistant S. aureus infections. A possible alterna...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3707109/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.4.608 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
